Hysterectomy Device Market By Disease type (Uterine Cancer, Fibroids, Chronic pelvic pain, Others), By Surgical approach (Vaginal hysterectomy, Laparoscopic hysterectomy, Robotic assisted laparoscopic hysterectomy, Abdominal hysterectomy), By End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Hysterectomy Device Market

Hysterectomy device s are used to perform hysterectomy surgeries which involve removal of uterus and around organs due to uterine cancer, fibroids, chronic pelvic pain, uterine prolapse, endometriosis and adenomyosis. These device s are designed to help surgeons safely and effectively remove the uterus and associated tissue while minimizing complications and reducing patient recovery time. A hysterectomy may involve the removal of nearby organs and tissues, including the ovaries and fallopian tubes, depending on the purpose of surgery.  

Key factors driving the growth of the hysterectomy device market include rise in prevalence of cancer disease especially uterine cancer led to increases the number of patients who needs a diagnosis and treatment which increased the adoption of hysterectomy procedure for treatment purpose supports the market growth. The most prevalent type of gynecological cancer, uterine cancer, affects women of all ages. Uterine cancer risk rises with age, and women over 50 are more likely to be diagnosed with the condition. 

 Hysterectomy is also used to treat other gynecologic disorders like endometriosis, uterine fibroids, and irregular uterine bleeding in addition to uterine cancer. Moreover rising prevalence of fibroids and demand for hysterectomy for treatment of the fibroids propels the market growth. For an instance, according to the U.S. Department of the Health & Human Services More than 200,000 hysterectomies are performed each year for uterine fibroids. 

In addition, growing awareness of women's health is one of the key drivers of the hysterectomy devices market. Various organizations are carrying out campaigns to rise awareness among women related to gynecological health. Furthermore, the market for hysterectomy devices has grown significantly owing to technological improvements. The procedure is now less invasive and has a shorter recovery period because of advances in minimally invasive surgical procedures including laparoscopic and robot-assisted hysterectomy. Moreover, the market for hysterectomy devices is expected to grow during the forecast period as a result of the rising focus on women's health and the availability of more cutting-edge, minimally invasive treatment alternatives. 

Some gynecologic diseases can be effectively treated by hysterectomy. It is a significant surgical treatment with potential risks and long-term effects, including menopause and infertility. As a result, the availability of alternative treatments may hinder the market growth for hysterectomy devices as patients choose less invasive procedures like hormone therapy or uterine artery embolization that may also result in quicker recovery times. Conversely, the market is anticipated to experience growth during the forecast period as a result of the rising demand for minimally invasive procedures and robotic-assisted surgeries. Due to their potential advantages, such as shorter hospital stays, less blood loss, and quicker recovery times when compared to conventional open surgery. 

The global hysterectomy device market is segmented into disease type, surgical approach, end user and region. By disease type, the market is categorized into uterine cancer, fibroids, chronic pelvic pain and others. On the basis of surgical approach, the market is segregated into vaginal hysterectomy, laparoscopic hysterectomy, robotic assisted laparoscopic hysterectomy and abdominal hysterectomy. On the basis of end user, the market is categorized into hospitals, ambulatory surgical center and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

The key players profiled in the study include Conkin surgical instruments ltd, Cooper Surgical, B. braun medical ltd, KARL STORZ GmbH & Co. KG, Conmed Corporation, Jhonson & Jhonson, Richard Wolf GmbH, Fortimedix Surgical, Medtronic corporation and Laborie, Inc. The players in the market have been actively engaged in the adoption various strategies such as acquisition to remain competitive and gain advantage over the competitors in the market. For instance, in May 2020, in February 2022, Cooper Companies announced it has signed a binding letter of intent to acquire Cook Medical’s Reproductive Health business, a manufacturer of minimally invasive medical devices focused on the fertility, obstetrics and gynecology markets. 

 

Key Market Insights (Updated) 

By disease type, the chronic pelvic pain segment was the largest revenue contributor to the market in 2021. However, the fibroids segment is anticipated to grow at the highest CAGR during the forecast period.   

By surgical approach, the abdominal hysterectomy segment dominated the global market in 2021. 

Based on end user, the hospital segment was the largest revenue contributor to the market in 2021 and is estimated to reach $261.8 million by 2031, with a CAGR of 5.9%. 

Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.  

Overview

The global hysterectomy device market was valued at $328.09 million in 2021 and is projected to reach $566.5 million by 2031, registering a CAGR of 5.63% from 2022 to 2031.   

The surgical removal of the uterus and, less frequently, the cervix is known as a hysterectomy. A hysterectomy may involve the removal of nearby organs and tissues, including the ovaries and fallopian tubes, depending on the reason for the surgery. It is typically performed as a treatment for a variety of gynecological conditions, such as uterine fibroids, endometriosis, and abnormal uterine bleeding. Hysterectomy can be performed using a variety of surgical techniques, including open surgery, laparoscopic surgery, and robot-assisted surgery.   

The driving factors for hysterectomy device market is rise in prevalence of uterine cancer. Uterine cancer is one of the most common gynecological cancers, and hysterectomy is a common treatment option for this disease. In addition, various government organizations and NGOs are creating awareness among the people about women’s health which also fuels the market growth. Moreover, hysterectomy devices have seen a number of technological advancements in recent years, which have improved surgical outcomes, decreased patient discomfort and recovery time also propels the market growth.  

However, factors such as availability of alternative treatment for the treatment of gynecological disorders expected to hinder the growth of hysterectomy device market. On the other hand, a surge in demand for minimally or less invasive surgeries is anticipated to offer growth opportunity for the market.  

The global hysterectomy device market is segmented into disease type, surgical approach, end user and region. By disease type, the market is categorized into uterine cancer, fibroids, chronic pelvic pain and others. On the basis of surgical approach, the market is segregated into vaginal hysterectomy, laparoscopic hysterectomy, robotic assisted laparoscopic hysterectomy and abdominal hysterectomy. On the basis of end user, the market is categorized into hospitals, ambulatory surgical center and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).  

Major Key players that operate in the global hysterectomy device market are Conkin surgical instruments ltd, Cooper Surgical, B. braun medical ltd, KARL STORZ GmbH & Co. KG, Conmed Corporation, Jhonson & Jhonson, Richard Wolf GmbH, Fortimedix Surgical, Medtronic corporation and Laborie, Inc. 

Key Benefits For Stakeholders

●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hysterectomy device market analysis from 2021 to 2031 to identify the prevailing hysterectomy device market opportunities.

●The market research is offered along with information related to key drivers, restraints, and opportunities.

●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

●In-depth analysis of the hysterectomy device market segmentation assists to determine the prevailing market opportunities.

●Major countries in each region are mapped according to their revenue contribution to the global market.

●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

●The report includes the analysis of the regional as well as global hysterectomy device market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ KARL STORZ GmbH & Co. K

Scope of Hysterectomy Device Market Report

1.1. Report description

1.2. Key market segments

1.3. Key benefits to the stakeholders

1.4. Research Methodology

1.4.1. Primary research

1.4.2. Secondary research

1.4.3. Analyst tools and models

2.1. CXO Perspective

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top impacting factors

3.2.2. Top investment pockets

3.3. Porter’s five forces analysis

3.3.1. Bargaining power of suppliers

3.3.2. Bargaining power of buyers

3.3.3. Threat of substitutes

3.3.4. Threat of new entrants

3.3.5. Intensity of rivalry

3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Rise in prevalence of uterine cancer

3.4.1.2. Increase in awareness of women’s health

3.4.1.3. Technological advancements in hysterectomy devices

3.4.2. Restraints

3.4.2.1. Availability of alternative treatments

3.4.3. Opportunities

3.4.3.1. Increase in demand for the minimally invasive procedures

3.5. COVID-19 Impact Analysis on the market

4.1. Overview

4.1.1. Market size and forecast

4.2. Uterine Cancer

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market share analysis by country

4.3. Fibroids

4.3.1. Key market trends, growth factors and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market share analysis by country

4.4. Chronic pelvic pain

4.4.1. Key market trends, growth factors and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market share analysis by country

4.5. Others

4.5.1. Key market trends, growth factors and opportunities

4.5.2. Market size and forecast, by region

4.5.3. Market share analysis by country

5.1. Overview

5.1.1. Market size and forecast

5.2. Vaginal hysterectomy

5.2.1. Key market trends, growth factors and opportunities

5.2.2. Market size and forecast, by region

5.2.3. Market share analysis by country

5.3. Laparoscopic hysterectomy

5.3.1. Key market trends, growth factors and opportunities

5.3.2. Market size and forecast, by region

5.3.3. Market share analysis by country

5.4. Robotic assisted laparoscopic hysterectomy

5.4.1. Key market trends, growth factors and opportunities

5.4.2. Market size and forecast, by region

5.4.3. Market share analysis by country

5.5. Abdominal hysterectomy

5.5.1. Key market trends, growth factors and opportunities

5.5.2. Market size and forecast, by region

5.5.3. Market share analysis by country

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Key market trends, growth factors and opportunities

6.2.2. Market size and forecast, by region

6.2.3. Market share analysis by country

6.3. Ambulatory Surgical Centers

6.3.1. Key market trends, growth factors and opportunities

6.3.2. Market size and forecast, by region

6.3.3. Market share analysis by country

6.4. Others

6.4.1. Key market trends, growth factors and opportunities

6.4.2. Market size and forecast, by region

6.4.3. Market share analysis by country

7.1. Overview

7.1.1. Market size and forecast By Region

7.2. North America

7.2.1. Key trends and opportunities

7.2.2. Market size and forecast, by Disease type

7.2.3. Market size and forecast, by Surgical approach

7.2.4. Market size and forecast, by End User

7.2.5. Market size and forecast, by country

7.2.5.1. U.S.

7.2.5.1.1. Key market trends, growth factors and opportunities

7.2.5.1.2. Market size and forecast, by Disease type

7.2.5.1.3. Market size and forecast, by Surgical approach

7.2.5.1.4. Market size and forecast, by End User

7.2.5.2. Canada

7.2.5.2.1. Key market trends, growth factors and opportunities

7.2.5.2.2. Market size and forecast, by Disease type

7.2.5.2.3. Market size and forecast, by Surgical approach

7.2.5.2.4. Market size and forecast, by End User

7.2.5.3. Mexico

7.2.5.3.1. Key market trends, growth factors and opportunities

7.2.5.3.2. Market size and forecast, by Disease type

7.2.5.3.3. Market size and forecast, by Surgical approach

7.2.5.3.4. Market size and forecast, by End User

7.3. Europe

7.3.1. Key trends and opportunities

7.3.2. Market size and forecast, by Disease type

7.3.3. Market size and forecast, by Surgical approach

7.3.4. Market size and forecast, by End User

7.3.5. Market size and forecast, by country

7.3.5.1. Germany

7.3.5.1.1. Key market trends, growth factors and opportunities

7.3.5.1.2. Market size and forecast, by Disease type

7.3.5.1.3. Market size and forecast, by Surgical approach

7.3.5.1.4. Market size and forecast, by End User

7.3.5.2. France

7.3.5.2.1. Key market trends, growth factors and opportunities

7.3.5.2.2. Market size and forecast, by Disease type

7.3.5.2.3. Market size and forecast, by Surgical approach

7.3.5.2.4. Market size and forecast, by End User

7.3.5.3. UK

7.3.5.3.1. Key market trends, growth factors and opportunities

7.3.5.3.2. Market size and forecast, by Disease type

7.3.5.3.3. Market size and forecast, by Surgical approach

7.3.5.3.4. Market size and forecast, by End User

7.3.5.4. Italy

7.3.5.4.1. Key market trends, growth factors and opportunities

7.3.5.4.2. Market size and forecast, by Disease type

7.3.5.4.3. Market size and forecast, by Surgical approach

7.3.5.4.4. Market size and forecast, by End User

7.3.5.5. Spain

7.3.5.5.1. Key market trends, growth factors and opportunities

7.3.5.5.2. Market size and forecast, by Disease type

7.3.5.5.3. Market size and forecast, by Surgical approach

7.3.5.5.4. Market size and forecast, by End User

7.3.5.6. Rest of Europe

7.3.5.6.1. Key market trends, growth factors and opportunities

7.3.5.6.2. Market size and forecast, by Disease type

7.3.5.6.3. Market size and forecast, by Surgical approach

7.3.5.6.4. Market size and forecast, by End User

7.4. Asia-Pacific

7.4.1. Key trends and opportunities

7.4.2. Market size and forecast, by Disease type

7.4.3. Market size and forecast, by Surgical approach

7.4.4. Market size and forecast, by End User

7.4.5. Market size and forecast, by country

7.4.5.1. Japan

7.4.5.1.1. Key market trends, growth factors and opportunities

7.4.5.1.2. Market size and forecast, by Disease type

7.4.5.1.3. Market size and forecast, by Surgical approach

7.4.5.1.4. Market size and forecast, by End User

7.4.5.2. China

7.4.5.2.1. Key market trends, growth factors and opportunities

7.4.5.2.2. Market size and forecast, by Disease type

7.4.5.2.3. Market size and forecast, by Surgical approach

7.4.5.2.4. Market size and forecast, by End User

7.4.5.3. India

7.4.5.3.1. Key market trends, growth factors and opportunities

7.4.5.3.2. Market size and forecast, by Disease type

7.4.5.3.3. Market size and forecast, by Surgical approach

7.4.5.3.4. Market size and forecast, by End User

7.4.5.4. Australia

7.4.5.4.1. Key market trends, growth factors and opportunities

7.4.5.4.2. Market size and forecast, by Disease type

7.4.5.4.3. Market size and forecast, by Surgical approach

7.4.5.4.4. Market size and forecast, by End User

7.4.5.5. South Korea

7.4.5.5.1. Key market trends, growth factors and opportunities

7.4.5.5.2. Market size and forecast, by Disease type

7.4.5.5.3. Market size and forecast, by Surgical approach

7.4.5.5.4. Market size and forecast, by End User

7.4.5.6. Rest of Asia-Pacific

7.4.5.6.1. Key market trends, growth factors and opportunities

7.4.5.6.2. Market size and forecast, by Disease type

7.4.5.6.3. Market size and forecast, by Surgical approach

7.4.5.6.4. Market size and forecast, by End User

7.5. LAMEA

7.5.1. Key trends and opportunities

7.5.2. Market size and forecast, by Disease type

7.5.3. Market size and forecast, by Surgical approach

7.5.4. Market size and forecast, by End User

7.5.5. Market size and forecast, by country

7.5.5.1. Brazil

7.5.5.1.1. Key market trends, growth factors and opportunities

7.5.5.1.2. Market size and forecast, by Disease type

7.5.5.1.3. Market size and forecast, by Surgical approach

7.5.5.1.4. Market size and forecast, by End User

7.5.5.2. Saudi Arabia

7.5.5.2.1. Key market trends, growth factors and opportunities

7.5.5.2.2. Market size and forecast, by Disease type

7.5.5.2.3. Market size and forecast, by Surgical approach

7.5.5.2.4. Market size and forecast, by End User

7.5.5.3. South Africa

7.5.5.3.1. Key market trends, growth factors and opportunities

7.5.5.3.2. Market size and forecast, by Disease type

7.5.5.3.3. Market size and forecast, by Surgical approach

7.5.5.3.4. Market size and forecast, by End User

7.5.5.4. Rest of LAMEA

7.5.5.4.1. Key market trends, growth factors and opportunities

7.5.5.4.2. Market size and forecast, by Disease type

7.5.5.4.3. Market size and forecast, by Surgical approach

7.5.5.4.4. Market size and forecast, by End User

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Top player positioning, 2021

9.1. Conkin surgical instruments ltd

9.1.1. Company overview

9.1.2. Key Executives

9.1.3. Company snapshot

9.1.4. Operating business segments

9.1.5. Product portfolio

9.2. KARL STORZ GmbH & Co. KG

9.2.1. Company overview

9.2.2. Key Executives

9.2.3. Company snapshot

9.2.4. Operating business segments

9.2.5. Product portfolio

9.3. CONMED Corporation

9.3.1. Company overview

9.3.2. Key Executives

9.3.3. Company snapshot

9.3.4. Operating business segments

9.3.5. Product portfolio

9.3.6. Business performance

9.4. Richard Wolf GmbH

9.4.1. Company overview

9.4.2. Key Executives

9.4.3. Company snapshot

9.4.4. Operating business segments

9.4.5. Product portfolio

9.5. fortimedix surgical b.v.

9.5.1. Company overview

9.5.2. Key Executives

9.5.3. Company snapshot

9.5.4. Operating business segments

9.5.5. Product portfolio

9.6. Johnson & Johnson

9.6.1. Company overview

9.6.2. Key Executives

9.6.3. Company snapshot

9.6.4. Operating business segments

9.6.5. Product portfolio

9.6.6. Business performance

9.7. Laborie, Inc

9.7.1. Company overview

9.7.2. Key Executives

9.7.3. Company snapshot

9.7.4. Operating business segments

9.7.5. Product portfolio

9.8. Cooper Companies, Inc.

9.8.1. Company overview

9.8.2. Key Executives

9.8.3. Company snapshot

9.8.4. Operating business segments

9.8.5. Product portfolio

9.8.6. Business performance

9.8.7. Key strategic moves and developments

9.9. B. Braun Melsungen AG

9.9.1. Company overview

9.9.2. Key Executives

9.9.3. Company snapshot

9.9.4. Operating business segments

9.9.5. Product portfolio

9.9.6. Business performance

9.10. Medtronic plc

9.10.1. Company overview

9.10.2. Key Executives

9.10.3. Company snapshot

9.10.4. Operating business segments

9.10.5. Product portfolio

9.10.6. Business performanc

LIST OF TABLES

TABLE 01. GLOBAL HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 02. HYSTERECTOMY DEVICE MARKET FOR UTERINE CANCER, BY REGION, 2021-2031 ($MILLION)

TABLE 03. HYSTERECTOMY DEVICE MARKET FOR FIBROIDS, BY REGION, 2021-2031 ($MILLION)

TABLE 04. HYSTERECTOMY DEVICE MARKET FOR CHRONIC PELVIC PAIN, BY REGION, 2021-2031 ($MILLION)

TABLE 05. HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 06. GLOBAL HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 07. HYSTERECTOMY DEVICE MARKET FOR VAGINAL HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)

TABLE 08. HYSTERECTOMY DEVICE MARKET FOR LAPAROSCOPIC HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)

TABLE 09. HYSTERECTOMY DEVICE MARKET FOR ROBOTIC ASSISTED LAPAROSCOPIC HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)

TABLE 10. HYSTERECTOMY DEVICE MARKET FOR ABDOMINAL HYSTERECTOMY, BY REGION, 2021-2031 ($MILLION)

TABLE 11. GLOBAL HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 12. HYSTERECTOMY DEVICE MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)

TABLE 13. HYSTERECTOMY DEVICE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 ($MILLION)

TABLE 14. HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)

TABLE 15. HYSTERECTOMY DEVICE MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 16. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 17. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 18. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 19. NORTH AMERICA HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 20. U.S. HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 21. U.S. HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 22. U.S. HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 23. CANADA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 24. CANADA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 25. CANADA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 26. MEXICO HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 27. MEXICO HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 28. MEXICO HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 29. EUROPE HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 30. EUROPE HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 31. EUROPE HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 32. EUROPE HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 33. GERMANY HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 34. GERMANY HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 35. GERMANY HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 36. FRANCE HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 37. FRANCE HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 38. FRANCE HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 39. UK HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 40. UK HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 41. UK HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 42. ITALY HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 43. ITALY HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 44. ITALY HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 45. SPAIN HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 46. SPAIN HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 47. SPAIN HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 48. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 49. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 50. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 51. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 52. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 53. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 54. ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 55. JAPAN HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 56. JAPAN HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 57. JAPAN HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 58. CHINA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 59. CHINA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 60. CHINA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 61. INDIA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 62. INDIA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 63. INDIA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 64. AUSTRALIA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 65. AUSTRALIA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 66. AUSTRALIA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 67. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 68. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 69. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 70. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 71. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 72. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 73. LAMEA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 74. LAMEA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 75. LAMEA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 76. LAMEA HYSTERECTOMY DEVICE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 77. BRAZIL HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 78. BRAZIL HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 79. BRAZIL HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 80. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 81. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 82. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 83. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 84. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 85. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 86. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)

TABLE 87. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021-2031 ($MILLION)

TABLE 88. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 89. CONKIN SURGICAL INSTRUMENTS LTD: KEY EXECUTIVES

TABLE 90. CONKIN SURGICAL INSTRUMENTS LTD: COMPANY SNAPSHOT

TABLE 91. CONKIN SURGICAL INSTRUMENTS LTD: PRODUCT SEGMENTS

TABLE 92. CONKIN SURGICAL INSTRUMENTS LTD: PRODUCT PORTFOLIO

TABLE 93. KARL STORZ GMBH & CO. KG: KEY EXECUTIVES

TABLE 94. KARL STORZ GMBH & CO. KG: COMPANY SNAPSHOT

TABLE 95. KARL STORZ GMBH & CO. KG: PRODUCT SEGMENTS

TABLE 96. KARL STORZ GMBH & CO. KG: PRODUCT PORTFOLIO

TABLE 97. CONMED CORPORATION: KEY EXECUTIVES

TABLE 98. CONMED CORPORATION: COMPANY SNAPSHOT

TABLE 99. CONMED CORPORATION: PRODUCT SEGMENTS

TABLE 100. CONMED CORPORATION: PRODUCT PORTFOLIO

TABLE 101. RICHARD WOLF GMBH: KEY EXECUTIVES

TABLE 102. RICHARD WOLF GMBH: COMPANY SNAPSHOT

TABLE 103. RICHARD WOLF GMBH: PRODUCT SEGMENTS

TABLE 104. RICHARD WOLF GMBH: PRODUCT PORTFOLIO

TABLE 105. FORTIMEDIX SURGICAL B.V.: KEY EXECUTIVES

TABLE 106. FORTIMEDIX SURGICAL B.V.: COMPANY SNAPSHOT

TABLE 107. FORTIMEDIX SURGICAL B.V.: PRODUCT SEGMENTS

TABLE 108. FORTIMEDIX SURGICAL B.V.: PRODUCT PORTFOLIO

TABLE 109. JOHNSON & JOHNSON: KEY EXECUTIVES

TABLE 110. JOHNSON & JOHNSON: COMPANY SNAPSHOT

TABLE 111. JOHNSON & JOHNSON: PRODUCT SEGMENTS

TABLE 112. JOHNSON & JOHNSON: PRODUCT PORTFOLIO

TABLE 113. LABORIE, INC: KEY EXECUTIVES

TABLE 114. LABORIE, INC: COMPANY SNAPSHOT

TABLE 115. LABORIE, INC: PRODUCT SEGMENTS

TABLE 116. LABORIE, INC: PRODUCT PORTFOLIO

TABLE 117. COOPER COMPANIES, INC.: KEY EXECUTIVES

TABLE 118. COOPER COMPANIES, INC.: COMPANY SNAPSHOT

TABLE 119. COOPER COMPANIES, INC.: PRODUCT SEGMENTS

TABLE 120. COOPER COMPANIES, INC.: PRODUCT PORTFOLIO

TABLE 121. COOPER COMPANIES, INC.: KEY STRATERGIES

TABLE 122. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES

TABLE 123. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT

TABLE 124. B. BRAUN MELSUNGEN AG: PRODUCT SEGMENTS

TABLE 125. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO

TABLE 126. MEDTRONIC PLC: KEY EXECUTIVES

TABLE 127. MEDTRONIC PLC: COMPANY SNAPSHOT

TABLE 128. MEDTRONIC PLC: PRODUCT SEGMENTS

TABLE 129. MEDTRONIC PLC: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. HYSTERECTOMY DEVICE MARKET, 2021-2031

FIGURE 02. SEGMENTATION OF HYSTERECTOMY DEVICE MARKET, 2021-2031

FIGURE 03. TOP INVESTMENT POCKETS IN HYSTERECTOMY DEVICE MARKET (2022-2031)

FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS

FIGURE 05. HIGH BARGAINING POWER OF BUYERS

FIGURE 06. MODERATE THREAT OF SUBSTITUTES

FIGURE 07. MODERATE THREAT OF NEW ENTRANTS

FIGURE 08. MODERATE INTENSITY OF RIVALRY

FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALHYSTERECTOMY DEVICE MARKET

FIGURE 10. HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE, 2021(%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR UTERINE CANCER, BY COUNTRY 2021-2031(%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR FIBROIDS, BY COUNTRY 2021-2031(%)

FIGURE 13. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR CHRONIC PELVIC PAIN, BY COUNTRY 2021-2031(%)

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)

FIGURE 15. HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH, 2021(%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR VAGINAL HYSTERECTOMY, BY COUNTRY 2021-2031(%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR LAPAROSCOPIC HYSTERECTOMY, BY COUNTRY 2021-2031(%)

FIGURE 18. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR ROBOTIC ASSISTED LAPAROSCOPIC HYSTERECTOMY, BY COUNTRY 2021-2031(%)

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR ABDOMINAL HYSTERECTOMY, BY COUNTRY 2021-2031(%)

FIGURE 20. HYSTERECTOMY DEVICE MARKET, BY END USER, 2021(%)

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)

FIGURE 22. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2021-2031(%)

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF HYSTERECTOMY DEVICE MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)

FIGURE 24. HYSTERECTOMY DEVICE MARKET BY REGION, 2021

FIGURE 25. U.S. HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 26. CANADA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 27. MEXICO HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 28. GERMANY HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 29. FRANCE HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 30. UK HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 31. ITALY HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 32. SPAIN HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 33. REST OF EUROPE HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 34. JAPAN HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 35. CHINA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 36. INDIA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 37. AUSTRALIA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 38. SOUTH KOREA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 39. REST OF ASIA-PACIFIC HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 40. BRAZIL HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 41. SAUDI ARABIA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 42. SOUTH AFRICA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 43. REST OF LAMEA HYSTERECTOMY DEVICE MARKET, 2021-2031 ($MILLION)

FIGURE 44. TOP WINNING STRATEGIES, BY YEAR

FIGURE 45. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 46. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 47. PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 48. COMPETITIVE DASHBOARD

FIGURE 49. COMPETITIVE HEATMAP: HYSTERECTOMY DEVICE MARKET

FIGURE 50. TOP PLAYER POSITIONING, 2021

FIGURE 51. CONMED CORPORATION: NET SALES, 2019-2021 ($MILLION)

FIGURE 52. CONMED CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 53. CONMED CORPORATION: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 54. JOHNSON & JOHNSON: NET SALES, 2020-2022 ($MILLION)

FIGURE 55. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 56. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2022 (%)

FIGURE 57. COOPER COMPANIES, INC.: NET REVENUE, 2019-2021 ($MILLION)

FIGURE 58. COOPER COMPANIES, INC.: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 59. B. BRAUN MELSUNGEN AG: NET SALES, 2019-2021 ($MILLION)

FIGURE 60. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY REGION, 2021 (%)

FIGURE 61. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY SEGMENT, 2021 (%)

FIGURE 62. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)

FIGURE 63. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)

FIGURE 64. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%